Opinion - (2025) Volume 10, Issue 4
Received: 01-Jul-2025, Manuscript No. jncr-26-190092;
Editor assigned: 03-Jul-2025, Pre QC No. P-190092;
Reviewed: 17-Jul-2025, QC No. Q-190092;
Revised: 22-Jul-2025, Manuscript No. R-190092;
Published:
29-Jul-2025
, DOI: 10.37421/2572-0813.2025.10.308
Citation: Petrova, Valentina. ”Nanomaterial Safety: Toxicology, Applications, and Risk Assessment.” J Nanosci Curr Res 10 (2025):308.
Copyright: © 2025 Petrova V. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
The rapidly expanding field of nanotoxicology is dedicated to the rigorous assessment of the safety profiles associated with novel nanomaterials. A significant challenge lies in the development and implementation of standardized methodologies essential for a comprehensive understanding of the potential risks posed by the widespread integration of nanomaterials, particularly within sensitive biomedical applications. The ongoing research in this domain addresses critical toxicological endpoints and grapples with the inherent difficulties in accurately predicting long-term effects, underscoring the imperative for robust risk assessment frameworks for these emerging technologies [1].
Furthermore, a deep understanding of the environmental implications and inherent toxicity of engineered nanoparticles is of paramount importance for sustainable development. Current research reviews the existing knowledge base concerning the ecotoxicological effects of various nanomaterials, meticulously detailing their environmental fate and transport dynamics across diverse ecological compartments. This necessitates the development of predictive models and the design of rigorous experimental protocols to guide responsible innovation and effectively mitigate ecological risks [2].
The cellular and molecular mechanisms underlying the toxicity of specific nanomaterials, such as silver nanoparticles (AgNPs), are actively being investigated in mammalian cell systems. Elucidation of the intricate pathways involved in oxidative stress, inflammation, and genotoxicity induced by AgNPs provides crucial insights into their potential health hazards. A key finding emphasizes the dose-dependent nature of these effects and the significant influence of nanoparticle physicochemical properties on observed toxicity [3].
In the realm of nanomedicine, the safety evaluation of nanoparticles employed for drug delivery necessitates a thorough comprehension of their complex biological interactions and potential adverse effects. Comprehensive reviews examine the immunotoxicity and biodistribution patterns of diverse nanoparticles utilized in therapeutic applications. These studies highlight the persistent challenges in reliably predicting in vivo responses from in vitro data and underscore the critical importance of stringent preclinical safety evaluations [4].
Investigating the impact of advanced nanomaterials, such as graphene-based materials, on respiratory health is another crucial area of research. Studies focus on elucidating the inflammatory responses and cellular damage induced by materials like graphene oxide in both lung epithelial cells and relevant in vivo models. The findings from such research underscore the absolute necessity for stringent handling procedures and effective exposure controls in occupational settings where these materials are utilized [5].
Addressing the critical need for standardized testing strategies in nanomaterial safety assessment presents both significant challenges and promising opportunities. This involves a detailed discussion on the importance of meticulously considering a range of physicochemical properties, including particle size, shape, surface chemistry, and aggregation state, in all toxicological evaluations. A proposed tiered approach to risk assessment integrates in vitro, in silico, and targeted in vivo studies to provide a more holistic safety profile [6].
The biological interactions of widely used titanium dioxide nanoparticles (TiO2 NPs) are under scrutiny, with a particular focus on their effects within the gastrointestinal tract. Research investigates cellular uptake mechanisms, potential disruption of the intestinal barrier function, and the induction of inflammatory responses in intestinal cells exposed to TiO2 NPs. This work highlights the essential need to assess oral exposure risks associated with nanomaterials used in food products [7].
Expanding into advanced applications, the toxicological implications of quantum dots (QDs) for biomedical imaging and sensing technologies are being thoroughly reviewed. The potential for cellular damage, genotoxicity, and organ accumulation is examined, with a strong emphasis placed on how surface functionalization significantly influences their overall safety profile. The authors advocate for more extensive long-term in vivo studies to fully comprehend the risks associated with QD usage [8].
A critical evaluation of the genotoxic potential of metal oxide nanoparticles (MONPs) is essential for understanding their safety. This review synthesizes findings from a variety of in vitro and in vivo studies that assess DNA damage, chromosomal aberrations, and mutagenicity induced by common MONPs such as ZnO and Fe2O3. The article emphasizes the crucial role of NP properties and experimental conditions in determining genotoxicity outcomes [9].
Finally, the in vivo toxicity of carbon nanotubes (CNTs) following pulmonary exposure is a critical area of investigation. Studies meticulously examine the inflammatory responses, fibrotic potential, and possible carcinogenicity linked to various types of CNTs. The findings strongly suggest the necessity for long-term epidemiological studies to accurately assess the occupational health risks associated with CNT exposure [10].
The burgeoning field of nanotoxicology is characterized by its intensive focus on evaluating the safety profiles of newly developed nanomaterials. A central theme in this discipline is the critical necessity for standardized assessment methodologies that are indispensable for a thorough understanding of the potential risks inherent in the widespread use of nanomaterials, especially within the critical domain of biomedical applications. The discourse within this field encompasses key toxicological endpoints and confronts the significant challenges associated with predicting long-term health consequences, thereby highlighting the paramount importance of comprehensive risk assessment for these burgeoning technologies [1].
Understanding the environmental impact and the potential toxicity of engineered nanoparticles is an absolutely crucial undertaking for the advancement of sustainable practices. This review synthesizes the current state of knowledge regarding the ecotoxicological effects attributed to various nanomaterials, detailing their complex fate and transport behaviors across different environmental matrices. The emphasis is placed on the urgent requirement for robust predictive models and well-designed experimental studies to guide responsible innovation and minimize potential ecological harm [2].
Investigating the cellular and molecular mechanisms that govern the toxicity of silver nanoparticles (AgNPs) within mammalian cells is a core area of current research. The study aims to elucidate the specific pathways involved in the induction of oxidative stress, inflammatory responses, and genotoxicity mediated by AgNPs, thereby offering valuable insights into their potential human health hazards. A significant observation highlights the pronounced dose-dependent nature of these toxic effects and the substantial influence exerted by the physicochemical properties of the nanoparticles on their toxicity [3].
In the context of nanomedicine, the safety assessment of nanoparticles utilized for drug delivery purposes mandates a profound understanding of their intricate biological interactions and potential for inducing side effects. This review delves into the immunotoxicity and biodistribution characteristics of a range of nanoparticles employed in nanomedicine. It further accentuates the inherent difficulties in accurately predicting in vivo biological responses based solely on in vitro data and stresses the indispensable role of rigorous preclinical safety evaluations [4].
Research into the impact of graphene-based nanomaterials on respiratory health is an active and important area of investigation. This study examines the inflammatory responses and cellular damage triggered by graphene oxide in both lung epithelial cells and relevant in vivo models. The findings derived from this research strongly underscore the essential need for meticulous handling protocols and stringent exposure control measures in occupational environments where graphene nanomaterials are utilized [5].
Efforts are continuously being made to develop standardized testing strategies for assessing nanomaterial safety, presenting both considerable challenges and valuable opportunities. This discussion highlights the critical importance of systematically considering various nanoparticle characteristics, including their size, shape, surface chemistry, and aggregation state, when conducting toxicological assessments. A proposed tiered approach to risk assessment seeks to integrate data from in vitro, in silico, and targeted in vivo studies for a more comprehensive safety evaluation [6].
The complex biological interactions of titanium dioxide nanoparticles (TiO2 NPs) are explored, with a specific focus on their effects on the gastrointestinal system. The study investigates cellular uptake phenomena, the disruption of intestinal barrier function, and the inflammatory responses observed in intestinal cells exposed to TiO2 NPs. This research emphasizes the necessity of evaluating the risks associated with oral exposure to nanomaterials that are incorporated into food products [7].
The toxicological implications associated with the use of quantum dots (QDs) in biomedical imaging and sensing applications are being actively reviewed. The potential for causing cellular damage, genotoxicity, and accumulation within various organs is examined, with a significant emphasis placed on how the surface functionalization of QDs impacts their safety profile. The authors strongly advocate for the execution of more extensive long-term in vivo studies to achieve a complete understanding of QD-related risks [8].
This review critically evaluates the genotoxic potential of metal oxide nanoparticles (MONPs), summarizing findings from a broad spectrum of in vitro and in vivo studies. The assessment includes data on DNA damage, chromosomal aberrations, and mutagenicity induced by common MONPs such as zinc oxide (ZnO) and iron(III) oxide (Fe2O3). The article underscores the critical importance of accounting for both the intrinsic properties of the nanoparticles and the specific experimental conditions employed when determining their genotoxic effects [9].
Finally, research into the in vivo toxicity of carbon nanotubes (CNTs) following pulmonary exposure is a key area of investigation. This study meticulously examines the inflammatory responses, the development of fibrosis, and the potential for carcinogenicity associated with different types of CNTs. The findings derived from this research highlight the crucial need for comprehensive long-term epidemiological studies to accurately assess the occupational health risks linked to CNT exposure [10].
This collection of research explores the multifaceted aspects of nanomaterial safety, covering nanotoxicology, ecotoxicology, and the implications of various nanoparticles in biomedical and industrial applications. Studies investigate the cellular and molecular mechanisms of toxicity for specific nanomaterials like silver nanoparticles and graphene oxide, highlighting dose-dependent effects and the influence of physicochemical properties. Concerns are raised regarding the environmental impact, respiratory health, gastrointestinal effects, and genotoxicity of nanoparticles such as titanium dioxide and metal oxides. The development of standardized testing strategies and the challenges in predicting in vivo responses from in vitro data are emphasized. Research also addresses the safety of nanoparticles in drug delivery, the toxicological perspectives of quantum dots, and the long-term pulmonary toxicity of carbon nanotubes, underscoring the need for comprehensive risk assessments and further in vivo and epidemiological studies.
None
None
Journal of Nanosciences: Current Research received 387 citations as per Google Scholar report
